investorscraft@gmail.com

Intrinsic ValueKorian (0OPS.L)

Previous Close£3.85
Intrinsic Value
Upside potential
Previous Close
£3.85

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2023 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Korian is a leading European provider of elderly care and specialized health services, operating across France, Germany, Italy, Spain, the Netherlands, and Belgium. The company’s revenue model is anchored in long-term care nursing homes, assisted living facilities, and home care services, catering to aging populations with increasing demand for medical and non-medical support. With approximately 850 care facilities and 91,808 beds as of 2021, Korian holds a strong market position in Europe’s fragmented elderly care sector. The company differentiates itself through integrated care solutions, combining residential, clinical, and home-based services to address diverse patient needs. Its geographic diversification mitigates country-specific regulatory risks while capitalizing on Europe’s aging demographic trends. Korian faces competition from public providers and smaller private operators but benefits from scale advantages in staffing, procurement, and regulatory compliance. The company’s focus on specialized care for chronic conditions and post-acute recovery further strengthens its positioning in higher-margin segments of the healthcare continuum.

Revenue Profitability And Efficiency

Korian reported FY2023 revenue of €4.996 billion, reflecting its large-scale operations in elderly care. However, the company posted a net loss of €92.4 million, with diluted EPS of -€0.87, indicating profitability challenges amid rising operational costs and potential regulatory pressures. Operating cash flow remained robust at €804.2 million, supporting liquidity despite significant capital expenditures of €484.1 million for facility maintenance and expansion.

Earnings Power And Capital Efficiency

The company’s negative net income suggests strained earnings power, likely due to high fixed costs in labor-intensive care facilities and debt servicing. Capital efficiency is pressured by substantial investments in maintaining and modernizing its extensive facility network, though operating cash flow generation demonstrates underlying cash-generating ability from core operations.

Balance Sheet And Financial Health

Korian’s balance sheet shows €677.9 million in cash against a high total debt burden of €8.14 billion, reflecting leveraged expansion in a capital-intensive sector. The debt-heavy structure may constrain financial flexibility, particularly in a rising interest rate environment, though the asset-backed nature of its real estate portfolio provides some collateral support.

Growth Trends And Dividend Policy

Growth is driven by Europe’s aging population, but recent financial performance shows strain. The company suspended dividends (€0 DPS in FY2023) to preserve capital, prioritizing debt management and operational stability over shareholder returns. Long-term demand trends remain favorable, but short-term execution risks persist.

Valuation And Market Expectations

With a market cap of €1.17 billion and a beta of 0.839, Korian trades at a discount to revenue multiples, reflecting investor concerns over profitability and leverage. The valuation suggests muted expectations for near-term earnings recovery despite sector tailwinds.

Strategic Advantages And Outlook

Korian’s scale and geographic diversification provide structural advantages in Europe’s elderly care market. However, the outlook remains cautious due to high leverage and operational margin pressures. Success hinges on improving cost efficiency, navigating labor shortages, and monetizing its integrated care model while managing debt obligations.

Sources

Company filings, market data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2024202520262027202820292030203120322033203420352036203720382039204020412042204320442045204620472048

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount